Multibagger Personal Care Company Q3 FY26 Update: Record Performance, Rs 335 Crore Revenue Guidance Upgrade and Saudi Arabia FMCG Expansion by 2027

DSIJ Intelligence-2Categories: Mindshare, Trendingjoin us on whatsappfollow us on googleprefered on google

Multibagger Personal Care Company Q3 FY26 Update: Record Performance, Rs 335 Crore Revenue Guidance Upgrade and Saudi Arabia FMCG Expansion by 2027

The shares of the company gave multibagger returns of 273 per cent from its 52-week low of Rs 50 per share and a whopping 1,400 per cent in 3 years.

Cupid Limited has reported strong operating momentum in its Q3 FY26 business update, with management indicating that the quarter is expected to be the company’s best performance to date. The company is currently operating with its highest-ever Order Book, offering clear revenue visibility for the coming quarters and reinforcing confidence in near-term growth.

On the back of this momentum, management expressed confidence in surpassing its earlier FY26 guidance of Rs 335 crore in revenue and Rs 100 crore in profit after Tax. Capacity expansion is underway at the Palava, Maharashtra facility to support rising volumes, while the company is also witnessing steady traction in its FMCG portfolio. Recently launched personal care products such as petroleum jelly and face wash are contributing to incremental demand and diversification beyond the core healthcare segment.

In a significant international expansion move, Cupid’s board has given in-principle approval for setting up an FMCG manufacturing facility in the Kingdom of Saudi Arabia. The proposed plant is aimed at catering to the GCC region and nearby export markets, many of which are USD-linked economies. The facility is targeted for completion by March 2027 and is expected to strengthen Cupid’s presence in overseas FMCG markets.

On the product development front, the company is awaiting WHO prequalification for its Malaria IVD kit and Version 3 Female Condom. These approvals could further enhance Cupid’s global addressable market and support exports through international health agencies. Additionally, Cupid disclosed that its investment in the GII Healthcare Investment Limited Fund has appreciated to around 1.2x the initial investment made in October 2025, reflecting improving returns on strategic financial investments.

About the Company

Established in 1993, CUPID Limited is a leading Indian manufacturer of male and female condoms, lubricants, and various other health and personal care products. The company has a strong global presence, exporting its products to over 110 countries, and is the first company worldwide to receive WHO/UNFPA pre-qualification for both male and female condoms. To meet growing demand, CUPID recently acquired land in Palava, Maharashtra, which will increase its production capacity by 1.5 times and allow it to expand its range of Fast-Moving Consumer Goods (FMCG) like fragrances and personal care items. This strategic expansion is part of the company's commitment to public health and international growth.

DSIJ’s 'Tiny Treasure' service recommends researched Small-Cap stocks with Inherent Growth Potential. If this interests you, do download the service details here.

The company has a market cap of over Rs 4,700 crore. The shares of the company gave multibagger returns of 273 per cent from its 52-week low of Rs 50 per share and a whopping 1,400 per cent in 3 years.

Disclaimer: The article is for informational purposes only and not investment advice.